These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24738044)

  • 21. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
    Kochiashvili G; Kochiashvili D
    Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat.
    Foster R; Jung J; Farooq A; McClung C; Ripsch MS; Fitzgerald MP; White FA
    Neuroscience; 2011 Jun; 183():230-7. PubMed ID: 21458542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
    Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
    Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.
    Keay SK; Zhang CO
    BJU Int; 2016 Jul; 118(1):161-72. PubMed ID: 26919663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms.
    Shan H; Zhang EW; Zhang P; Zhang XD; Zhang N; Du P; Yang Y
    BMC Urol; 2019 Nov; 19(1):115. PubMed ID: 31718622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome.
    Gheinani AH; Burkhard FC; Monastyrskaya K
    Cell Mol Life Sci; 2013 Oct; 70(20):3773-89. PubMed ID: 23463234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS).
    Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
    Expert Opin Emerg Drugs; 2015; 20(4):555-70. PubMed ID: 26535808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
    Castro-Diaz D; Cardozo L; Chapple CR; Espuña M; Kelleher C; Kirby M; Milsom I; Sievert KD; Tubaro A
    Int J Clin Pract; 2014 Mar; 68(3):356-62. PubMed ID: 24373133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
    Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
    Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
    Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
    Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
    Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy.
    Cervigni M
    Transl Androl Urol; 2015 Dec; 4(6):638-42. PubMed ID: 26816865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
    Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
    Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study.
    Schrepf A; Bradley CS; O'Donnell M; Luo Y; Harte SE; Kreder K; Lutgendorf S;
    Brain Behav Immun; 2015 Oct; 49():66-74. PubMed ID: 25771510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Urinary Tract Markers in Interstitial Cystitis/Bladder Pain Syndrome.
    Grigorescu B; Powers K; Lazarou G
    Female Pelvic Med Reconstr Surg; 2016; 22(1):16-23. PubMed ID: 26571430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
    Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
    Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
    Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
    Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P
    Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis.
    Zhang X; He H; Lu G; Xu T; Qin L; Wang X; Jin X; Liu B; Zhao Z; Shen Z; Shao Y
    Sci Rep; 2016 Oct; 6():35672. PubMed ID: 27782122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.